Bronchodilator effect of inhaled olprinone, a phosphodiesterase 3 inhibitor, in asthmatic patients

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 3, 1999, Pages 817-820

  Myou, Shigeharu ^a   Fujimura, Masaki ^b   Kamio, Yumie ^b   Ishiura, Yoshihisa ^b   Tachibana, Hideki ^b   Hirose, Tatsuki ^b   Hashimoto, Takuma ^b   Matsuda, Tamotsu ^b  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LOPRINONE; PHOSPHODIESTERASE INHIBITOR; SALBUTAMOL;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHODILATATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOOTH MUSCLE RELAXATION; WHEEZING;

EID: 0032845131     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.3.9812065     Document Type: Article

References (18)

1. Torphy, T. J., and B. J. Undem. 1991. Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax 46:512-523.
2. Giembycz, M. A., M. G. Belvisi, M. Miura, R. S. Perkins, J. Kelly, S. Tadjkarimi, M. H. Yacoub, and P. J. Barnes. 1992. Soluble cyclic nucleotide phosphodiesterase isoenzymes from human tracheal smooth muscle (abstract). Br. J. Pharmacol. 107:52.
3. Rabe, K. F., H. Tenor, G. Dent, C. Schudt, S. Liebig, and H. Magnussen. 1993. Phosphodiesterase isoenzymes modulating inherent tone in human airways: identification and characterization. Am. J. Physiol. 264: L458-L464.
4. de Boer, J., K. J. Philpott, R. G. M. van Amsterdam, M. Shahid, H. Zaagsma, and C. D. Nicholson. 1992. Human bronchial cyclic nucleotide phosphodiesterase isoenzymes: biochemical and pharmacological analysis using selective inhibitors. Br. J. Pharmacol. 106:1028-1034.
5. Fujimura, M., Y. Kamio, S. Myou, T. Hashimoto, and T. Matsuda. 1997. Effect of a phosphodiesterase 3 inhibitor, cilostazol, on bronchial hyperresponsiveness in elderly patients with asthma. Int. Arch. Allergy Immunol. 114:379-384.
6. Bardin, P. G., M. A. Dorward, F. C. Lampe, B. Franke, and S. T. Holgate. 1998. Effect of selective phosphodiesterase 3 inhibition on the early and late asthmatic responses to inhaled allergen. Br. J. Clin. Pharmacol. 45:387-391.
7. Howell, R. E., B. D. Sickels, and S. L. Woeppel. 1993. Pulmonary anti-allergic and bronchodilalor effects of isozyme-selective phosphodi-esterase inhibitors in guinea pigs. J. Pharmacol. Exp. Ther. 264:609-615.
8. Fujimura, M., Y. Kamio, M. Saito, T. Hashimoto, and T. Matsuda. 1995. Bronchodilator and bronchoprotective effects of cilostazol in humans in vivo. Am. J. Respir. Crit. Care Med. 151:222-225.
9. Leeman, M., P. Lejeune, C. Melot, and R. Nacije. 1987. Reduction in pulmonary hypertension and in airway resistances by enoximone (MDL 17,043) in decompensated COPD. Chest 91:662-666.
10. Hu, H., M. Takata, I. Kusakawa, M. Fujita, and K. Miyasaka. 1995. Intratracheal administration of phosphodiesterase 3 inhibitor attenuates bronchoconstriction in cats. Pediatr. Pulmonol. 19:360-364.
11. Ortiz, J. L., J. M. Vallés, M. Mart́-Cabrera, J. Cortijo, and E. J. Morcillo. 1996. Effects of selective phosphodiesterase inhibitors on platelet-activating factor- and antigen-induced airway hyperreactivity, eosinophil accumulation, and microvascular leakage in guinea pigs. Naunyn-Schmiedeberg's Arch. Pharmacol. 353:200-206.
12. Brunnée, T., R. Engelstätter, V. W. Steinijans, and G. Kunkel. 1992. Bronchodilatory effect of inhaled zardaverine, a phosphodiesterase III and IV inhibitor, in patients with asthma. Eur. Respir. J. 5:982-985.
13. Ogawa, T., H. Ohhara, H. Tsunoda, J. Kuroki, and T. Shoji. 1989. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. Ist communication: studies on isolated guinea pig cardiac muscles. Arzneim.-Forsch./Drug Res. 39:33-37.
14. Sugioka, M., M. Ito, H. Masuoka, K. Ichikawa, T. Konishi, T. Tanaka, and T. Nakano. 1994. Identification and characterization of isoenzymes of cyclic nucleotide phosphodiesterase in human kidney and heart, and the effects of new cardiotonic agents on these isoenzymes. Naunyn Schmiedeberg's Arch. Pharmacol. 350:284-293.
15. American Thoracic Society. 1987. Standard for diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am. Rev. Respir. Dis. 136:225-244.
16. American Thoracic Society. 1987. Standardization of spirometry 1987 update. Am. Rev. Respir. Dis. 136:1285-1298.
17. Foster, R. W., K. Rakshi, J. R. Carpenter, and R. C. Small. 1992. Trials of the bronchodilator activity of the isozyme-selective phosphodiesterase inhibitor AH 21-123 in healthy volunteers during a methacholine challenge test. Br. J. Clin. Pharmacol. 34:527-543.
18. Bachelet, M., D. Vincent, N. Havet, R. Marrash-Chahla, A. Pradalier, J. Dry, and B. B. Vargaftig. 1991. Reduced responsiveness of adenylate cyclase in alveolar macrophages from patients with asthma. J. Allergy Clin. Immunol. 88:322-328.